Co-Scheduled Newborn and Contraception Care for Postpartum Women
(LINCC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Pregnancies conceived within 18 months of a prior delivery (termed short inter-pregnancy interval \[IPI\]) place mothers and infants at high risk for poor health outcomes and affect nearly one third of women in the U.S. Rates of postpartum (PP) contraception use remain low, particularly among low-income minority women, leading to high rates of short IPI pregnancies. This proposed study aims to address the gap in the current model of PP contraception care, by developing and implementing a novel approach to link (co-schedule) PP contraception care with newborn well-baby care with the goal of improving access to timely PP contraception.
Who Is on the Research Team?
Sadia Haider, MD
Principal Investigator
Rush University Medical Center
Rachel Caskey, MD
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for women who have recently given birth and are visiting one of the selected 7 CHC sites with their infants for the first well-baby visit, typically 3-5 days post-delivery. It's not open to men, or women who had tubal ligation or planned long-term birth control right after delivery, nor those who needed an emergency hysterectomy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive co-scheduled postpartum contraception and newborn care visits
Follow-up
Participants are monitored for receipt of contraception and short inter-pregnancy interval pregnancies
What Are the Treatments Tested in This Trial?
Interventions
- LINCC intervention - enable co-schedule feature
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
AllianceChicago
Collaborator
University of Illinois at Chicago
Collaborator